Kushnir, Vitaly A.
Darmon, Sarah K.
Barad, David H.
Weghofer, Andrea
Gleicher, Norbert
Funding for this research was provided by:
Foundation for Reproductive Medicine (n/a)
Center for Human Reproduction (n/a)
Article History
Received: 19 July 2018
Accepted: 1 October 2018
First Online: 11 October 2018
Compliance with ethical standards
:
: N.G. and D.H.B. are co-inventors on several pending and already awarded U.S. patents claiming fertility benefits from androgen supplementation in women with low functional ovarian reserve (LFOR). Both receive royalties from Fertility Nutraceuticals, LLC, in which N.G. also holds shares. Other authors declare that they have no conflict of interest.
: This study received Institutional Review Board (IRB) approval (ER11052015-01) on 11/11/2015 from the IRB of the Center for Human Reproduction. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.